At a glance
ClinicalIndex Comparison RecordN/ACompleted· 46 enrolled
Drug / intervention
APS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study of a Single, Intra-Articular Injection of Autologous Protein Solution (APS) in Patients With Osteoarthritis (OA) of the Knee
In Brief
A clinical study evaluating APS and Saline for Osteoarthritis, Knee. Completed, enrolled 46 participants across 4 sites in 4 countries.
Detailed Summary
This double-blind, multicenter, randomized, controlled trial (RCT) will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with osteoarthritis (OA) of the knee who have failed at least 1 conservative osteoarthritis (OA) therapy (e.g. physiotherapy, simple analgesics, intra-articular injection).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesAustria, Belgium, Italy, Norway
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedMay 2014
Primary CompletionOct 2015
Study CompletionSep 2020
TodayJul 2026
First PostedMay 15, 2014
Enrollment StartMay 1, 2014
Primary CompletionOct 1, 2015
Study CompletionSep 15, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 12.1 years ago
Interventions
APSdevice
Intra-articular Injection
Salinedevice
Intra-articular injection